British Journal of Oral and Maxillofacial Surgery
Volume 48, Issue 6 , Pages 434-437 , September 2010

Expression and importance of inhibitor of DNA binding helix–loop–helix protein in salivary adenoid cystic carcinoma

  • Xie WeiHong

      Affiliations

    • Shanghai Key Laboratory of Stomatology, Department of Oral and Maxillofacial Surgery, Ninth People's Hospital, School of Stomatology, Shanghai Jiao Tong University, Shanghai 200011, China
    • Present address: Department of Oral and Maxillofacial Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
    • ,
  • Li XinMing

      Affiliations

    • Department of Oral and Maxillofacial Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, 450052, China
    • ,
  • Ren GuoXin

      Affiliations

    • Shanghai Key Laboratory of Stomatology, Department of Oral and Maxillofacial Surgery, Ninth People's Hospital, School of Stomatology, Shanghai Jiao Tong University, Shanghai 200011, China
    • Corresponding Author InformationCorresponding authors. Tel.: +86 021 63135129.
    • ,
  • Guo Wei

      Affiliations

    • Shanghai Key Laboratory of Stomatology, Department of Oral and Maxillofacial Surgery, Ninth People's Hospital, School of Stomatology, Shanghai Jiao Tong University, Shanghai 200011, China
    • Corresponding Author InformationCorresponding authors. Tel.: +86 021 63135129.

,Accepted 11 August 2009.

References 

  1. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: a negative regulator of helix–loop–helix DNA binding proteins. Cell. 1990;61:49–59
  2. Ouyang XS, Wang X, Lee DT, Tsao SY, Wong YC. Overexpression of Id-1 in prostate cancer. J Urol. 2002;167:2598–2602
  3. Schindl M, Schoppmann SF, Ströbel T, Heinzl H, Leisser C, Horvat R, et al. Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin Cancer Res. 2003;9:779–785
  4. Nishimine M, Nakamura M, Mishima K, Kishi M, Kirita T, Sugimura M, et al. Id proteins are overexpressed in human oral squamous cell carcinomas. J Oral Pathol Med. 2003;32:350–357
  5. Han S, Gou C, Hong L, Liu J, ZheyiHan , Liu C, et al. Expression and significances of Id1 helix–loop–helix protein overexpression in gastric cancer. Cancer Lett. 2004;216:63–71
  6. Fong S, Itahana Y, Sumida T, Singh J, Coppe JP, Liu Y, et al. Id1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci USA. 2003;100:13543–13548
  7. Lee KT, Lee YW, Lee JK, Choi SH, Rhee JC, Paik SS, et al. Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers. Br J Cancer. 2004;90:1198–1203
  8. Polsky D, Young AZ, Busam KJ, Alani RM. The transcriptional repressor of p16/ink4a, id1, is up-regulated in early melanomas. Cancer Res. 2001;61:6008–6011
  9. Prabhu S, Ignatova A, Park ST, Sun XH. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol Cell Biol. 1997;17:5888–5896
  10. Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells. Oncogene. 2003;22:4498–4508
  11. Ling MT, Wang X, Ouyang XS, Lee TK, Fan TY, Xu K, et al. Activation of MAPK signaling pathway is essential for Id1 induced serum independent prostate cancer cell growth. Oncogene. 2002;21:8498–8505
  12. Zhang X, Ling MT, Feng H, Wong YC, Tsao SW, Wang X. Id-1 stimulates cell proliferation through activation of EGFR in ovarian cancer cells. Br J Cancer. 2004;91:2042–2047
  13. Ling MT, Lau TC, Zhou C, Chua CW, Kwok WK, Wang Q, et al. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis. 2005;26:1668–1676
  14. Volpert OV, Pili R, Sikder HA, Nelius T, Zaichuk T, Morris C, et al. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell. 2002;2:473–483
  15. Singh J, Murata K, Itahana Y, Desprez PY. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex. Oncogene. 2002;21:1812–1822
  16. Lin JC, Chang SY, Hsieh DS, Lee CF, Yu DS. Modulation of mitogen-activated protein kinase cascades by differentiation-1 protein: acquired drug resistance of hormone independent prostate cancer cells. J Urol. 2005;174:2022–2026
  17. Fong S, Debs RJ, Desprez PY. Id genes and proteins as promising targets in cancer therapy. Trends Mol Med. 2004;10:387–392
  18. Dodd RL, Slevin NJ. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol. 2006;42:759–769
  19. Schoppmann SF, Schindl M, Bayer G, Aumayr K, Dienes J, Horvat R, et al. Overexpression of Id is associated with poor clinical outcome in node negative breast cancer. Int J Cancer. 2003;104:677–682
  20. Perk J, Iavarone A, Benezra R. Id family of helix–loop–helix proteins in cancer. Nat Rev Cancer. 2005;5:603–614
  21. An J, Sun JY, Yuan Q, Tian HY, Qiu WL, Guo W, et al. Proteomics analysis of differentially expressed metastasis-associated proteins in adenoid cystic carcinoma cell lines of human salivary gland. Oral Oncol. 2004;40:400–408
  22. Spiro RH, Huvos AG. Stage means more than grade in adenoid cystic carcinoma. Am J Surg. 1992;164:623–628
  23. Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res. 2001;61:5703–5706
  24. Tsuchiya T, Okaji Y, Tsuno NH, Sakurai D, Tsuchiya N, Kawai K, et al. Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer. Cancer Sci. 2005;96:784–790

PII: S0266-4356(09)00497-5

doi: 10.1016/j.bjoms.2009.08.008

British Journal of Oral and Maxillofacial Surgery
Volume 48, Issue 6 , Pages 434-437 , September 2010

Article Tools

* Image Usage & Resolution